| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.62▼ | 5.57▲ | 5.54▲ | 5.53▲ | 4.57▲ |
| MA10 | 5.60▲ | 5.51▲ | 5.37▲ | 5.16▲ | 4.64▲ |
| MA20 | 5.58▲ | 5.33▲ | 5.35▲ | 4.60▲ | 4.35▲ |
| MA50 | 5.53▲ | 5.52▲ | 5.45▲ | 4.70▲ | 4.69▲ |
| MA100 | 5.36▲ | 5.37▲ | 4.82▲ | 4.31▲ | 6.04▼ |
| MA200 | 5.33▲ | 4.76▲ | 4.46▲ | 4.55▲ | 7.15▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | 0.051▲ | 0.040▲ | 0.135▲ | 0.162▲ |
| RSI | 59.619▲ | 66.432▲ | 59.139▲ | 61.936▲ | 60.979▲ |
| STOCH | 79.570 | 89.685▲ | 90.279▲ | 62.477 | 32.947 |
| WILL %R | -26.923 | -5.785▲ | -5.738▲ | -33.868 | -28.376 |
| CCI | 57.534 | 89.781 | 126.694▲ | 58.536 | 131.928▲ |
|
Thursday, January 29, 2026 03:12 PM
Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, announced the closing of its previously announced registered ...
|
|
Monday, January 19, 2026 10:52 AM
Universal Health Services (NYSE:UHS) operates diversified healthcare facilities and appears in broader Russell 1000 discussions.
|
|
Tuesday, January 06, 2026 08:53 AM
Altimmune ALT announced that the FDA has granted Breakthrough Therapy Designation to its lead pipeline candidate, pemvidutide, a novel, investigational GLP-1/glucagon dual receptor agonist, for the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/01/26 | 5.05 | 5.655 | 5.03 | 5.60 | 6,269,600 |
| 29/01/26 | 5.21 | 5.49 | 5.03 | 5.10 | 4,070,791 |
| 28/01/26 | 5.97 | 6.36 | 5.04 | 5.12 | 12,991,209 |
| 27/01/26 | 5.66 | 6.22 | 5.61 | 6.18 | 5,640,720 |
| 26/01/26 | 5.46 | 5.685 | 5.19 | 5.66 | 5,537,008 |
| 23/01/26 | 5.40 | 6.4399 | 5.3413 | 5.50 | 15,365,002 |
| 22/01/26 | 4.65 | 5.40 | 4.65 | 5.38 | 7,692,642 |
| 21/01/26 | 4.25 | 4.625 | 4.19 | 4.62 | 3,895,300 |
| 20/01/26 | 4.10 | 4.26 | 4.03 | 4.23 | 4,499,311 |
| 16/01/26 | 4.30 | 4.37 | 4.17 | 4.24 | 2,523,481 |
|
|
||||
|
|
||||
|
|